Avalo Therapeutics, Inc. (AVTX)

Avalo Therapeutics Statistics

Total Valuation

AVTX has a market cap or net worth of $52.51 million. The enterprise value is -$81.55 million.

Market Cap	52.51M
Enterprise Value	-81.55M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, before market open.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

AVTX has 10.67 million shares outstanding. The number of shares has increased by 2,599.19% in one year.

Current Share Class	10.67M
Shares Outstanding	10.67M
Shares Change (YoY)	+2,599.19%
Shares Change (QoQ)	-5.13%
Owned by Insiders (%)	5.94%
Owned by Institutions (%)	20.75%
Float	3.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	48.98
Forward PS	n/a
PB Ratio	0.38
P/TBV Ratio	0.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.96, with a Debt / Equity ratio of 0.01.

Current Ratio	19.96
Quick Ratio	19.42
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -50.06% and return on invested capital (ROIC) is -35.69%.

Return on Equity (ROE)	-50.06%
Return on Assets (ROA)	-29.75%
Return on Invested Capital (ROIC)	-35.69%
Return on Capital Employed (ROCE)	-28.43%
Revenue Per Employee	$19,174
Profits Per Employee	-$1.53M
Employee Count	23
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, AVTX has paid $114,000 in taxes.

Income Tax	114,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.15% in the last 52 weeks. The beta is 0.72, so AVTX's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	-62.15%
50-Day Moving Average	6.84
200-Day Moving Average	9.14
Relative Strength Index (RSI)	36.94
Average Volume (20 Days)	62,455

Short Selling Information

The latest short interest is 115,733, so 1.08% of the outstanding shares have been sold short.

Short Interest	115,733
Short Previous Month	96,156
Short % of Shares Out	1.08%
Short % of Float	3.14%
Short Ratio (days to cover)	1.11

Income Statement

In the last 12 months, AVTX had revenue of $441,000 and -$35.13 million in losses. Loss per share was -$20.91.

Revenue	441,000
Gross Profit	-14.84M
Operating Income	-40.87M
Pretax Income	-142.87M
Net Income	-35.13M
EBITDA	-40.70M
EBIT	-40.87M
Loss Per Share	-$20.91

Balance Sheet

The company has $134.55 million in cash and $918,000 in debt, giving a net cash position of $133.63 million or $12.52 per share.

Cash & Cash Equivalents	134.55M
Total Debt	918,000
Net Cash	133.63M
Net Cash Per Share	$12.52
Equity (Book Value)	133.03M
Book Value Per Share	12.70
Working Capital	131.93M

Cash Flow

Operating Cash Flow	-49.06M
Capital Expenditures	n/a
Free Cash Flow	-49.06M
FCF Per Share	-$4.60

Margins

Gross Margin	n/a
Operating Margin	-9,267.80%
Pretax Margin	-7,939.91%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2,599.19%
Shareholder Yield	-2,599.19%
Earnings Yield	-67.45%
FCF Yield	-94.20%

Analyst Forecast

The average price target for AVTX is $34.20, which is 595.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$34.20
Price Target Difference	595.12%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	82.86%
EPS Growth Forecast (5Y)	-28.78%

Stock Splits

The last stock split was on December 29, 2023. It was a reverse split with a ratio of 0.0041667:1.

Last Split Date	Dec 29, 2023
Split Type	Reverse
Split Ratio	0.0041667:1

Scores

AVTX has an Altman Z-Score of -1.78 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.78
Piotroski F-Score	1